HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients: (Trends in Molecular Medicine, 30:3 p:278-294, 2024)
1 Institute of Molecular Biology and Pathology, National Research Council of Italy, Rome, Italy.
2 Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
3 New Drug Incubator, Italfarmaco SpA, Milan, Italy.
4 Development, Aging, and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. Electronic address: lpuri@sbpdiscovery.org.